middle.news
Vitrafy Life Sciences Accelerates Growth with $35M IPO and US Expansion
6:36pm on Sunday 1st of June, 2025 AEST
•
Life Sciences
Read Story
Vitrafy Life Sciences Accelerates Growth with $35M IPO and US Expansion
6:36pm on Sunday 1st of June, 2025 AEST
Key Points
Completed $35 million IPO and ASX listing in November 2024
Positive validation in salmon aquaculture and bovine semen cryopreservation
Initiated North American expansion with key hires underway
Development of next-gen Cryopreservation Unit 2.0 and LifeChain software progressing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE